Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pfizer Inc
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGING STUDY EVALUATING THE EFFICACY AND SAFETY OF TANEZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH INTERSTITIAL CYSTITIS/ PAINFUL BLADDER SYNDROME (IC/PBS)
To characterize the dose response for tanezumab when administered by SC injection at an 8-weekly interval (2 injections) for moderate to severe chronic pain associated with (IC/PBS). To evaluate the...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc
Update Il y a 4 ans
AXITINIB (AG-013736) AS SECOND LINE THERAPY FOR METASTATIC RENAL CELL CANCER: AXIS TRIAL AXITINIB (AG 013736) COME TRATTAMENTO DI SECONDA LINEA PER L'ADENOCARCINOMA RENALE METASTATICO (AXIS)
Compare the Progression-Free Survival (PFS) of patients with mRCC receiving AG-013736 (axitinib) vs sorafenib following failure of one prior systemic first-line regimen containing one or more of the...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc., 235 East 42nd Street, New York, NY 110017
Update Il y a 4 ans
PHASE 1 SAFETY AND TOLERABILITY STUDY OF FIGITUMUMAB COMBINED WITH PEGVISOMANT IN PATIENTS WITH ADVANCED SOLID TUMORS
To evaluate the safety and tolerability of figitumumab plus pegvisomant in patients with advanced solid tumors.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
PILOT STUDY OF NOVEL COMBINATION OF MARAVIROC +ATAZANAVIR/RITONAVIR VS ATAZANAVIR/RITONAVIR +EMTRICITABINE/TENOFOVIR FOR THE TREATMENT OF TREATMENT NAÏVE HIV-INFECTED PATIENTS WITH R5 HIV-1
To examine if the combination of maraviroc (SelzentryTM, Celsentri®) and atazanavir/ritonavir is effective for the treatment of treatment-naïve HIV-1 infected subjects as measured by the percentage of...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
Study to test whether PF-06480605 is safe and improves symptoms in patients with ulcerative colitis
- To evaluate the safety and tolerability of PF-06480605 in subjects with moderate to severe UC. - To evaluate the efficacy of PF-06480605 in induction of endoscopic improvement (as assessed by Mayo ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®
To assess the impact of prophylactic paracetamol or ibuprofen administration on the immunogenicity of 13vPnC as measured by serotype-specific IgG geometric mean concentrations (GMCs) after completio...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer B.V. (The Netherlands) (Pfizer Inc, New York, USA)
Update Il y a 4 ans
A study on the tissue responsiveness to short term exogenous growth hormone in children with idiopathic short stature in relation to their response to long-term treatment
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc
Update Il y a 4 ans
A 12-WEEK PROOF OF CONCEPT STUDY FOR PF-04991532 IN T2DM SUBJECTS
To evaluate the dose response of PF 04991532 administered once daily over 12 weeks on HbA1c in adults with T2DM on stable doses of metformin.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumor
To characterize the plasma PK profile of sunitinib and its active metabolite SU012662 in children and young adults with advanced GIST.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pfizer Inc.235 East 42nd Street, New York, NY 10017
Update Il y a 4 ans
A clinical trial to determine if the investigational MnB vaccine works the same every time a batch (or lot) of the vaccine is made
Co-Primary To demonstrate that the immune response induced by 3 lots of rLP2086 vaccine are equivalent as measured by serum bactericidal assay using human complement (hSBA) performed with MnB strai...
Country
None
organs
None
Specialty
None
unknown
More information
Previous
8
9
10
11
12
13
14
15
16
17
Next